Congratulations,?General Prognostics (GPx)!???? We’re proud to support this forward-thinking #MedTech startup working to change the game of cardiac monitoring. GPx will also join our next Elev X! Boost batch to refine its revolutionary product, CardioID. This tech wearable is the first implant and needle-free device for heart failure patients. It uses advanced #MachineLearning to create highly accurate predictive models while tracking key metrics like heart rate and variability. Find out more here >>>?bit.ly/3YHigl8 #EmergingTechnology #Entrepreneur #StartUp #StartUpInvestor #MedTechStartup #TechWearables
关于我们
General Prognostics (GPx) is revolutionizing remote chronic disease management with the world's first bloodless blood tests. Headquartered in Boston, MA, GPx is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.
- 网站
-
https://gpx.ai
General Prognostics (GPx)的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 11-50 人
- 总部
- Boston，MA
- 类型
- 私人持股
- 创立
- 2020
产品
地点
-
主要
获取路线
US，MA，Boston，02110
General Prognostics (GPx)员工
动态
-
Co-Founder@General Prognostics (GPx) | Revolutionizing Chronic Disease Management
?? Exciting News?? ???? 令和6年度 「革新的医療技術研究開発推進事業（産学官共同型）」採択のお知らせ ???? General Prognostics (GPx) has been awarded $9M federal government grant by AMED (Japan Agency for Medical Research and Development)!!! We will be launching a 400-patient study in Japan with the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University! #Bloodlessbloodtests #heartfailure #remotepatientmonitoring https://lnkd.in/ewHwKeyJ
-
Co-Founder@General Prognostics (GPx) | Revolutionizing Chronic Disease Management
Another exciting partnership for General Prognostics (GPx), this time with NEC X Inc.! Let's go ?? Thank you to Shintaro Matsumoto, Naoto Mizuguchi, Mai Takeuchi, Rui Ueno, Ryoko Hirano, and Aya Iwata for making #bloodlessbloodtests come to life! #heartfailure #remotepatientmonitoring https://lnkd.in/eVw_erjW https://lnkd.in/eXdDtmAK
NEC X、慢性疾患患者向けにウェアラブルデバイスを用いた遠隔モニタリングソリューションを提供するGPx社に出資
prtimes.jp
-
Check out my episode on #AI in #Healthcare on Mayo Clinic’s podcast, Tomorrow’s Cure! Proud to have Javier Echenique and General Prognostics (GPx) be apart of this opportunity to share some thoughts with a great conversation! Hope you enjoy it ?? https://lnkd.in/ekXJ7bCH With Tia R. Ford Hetal Bhatt Mayo Clinic Press Artificial Intelligence
How AI is transforming organ transplants | Tomorrow's Cure Episode 6
https://www.youtube.com/
-
Co-Founder@General Prognostics (GPx) | Revolutionizing Chronic Disease Management
Join General Prognostics (GPx) in Boston for #THT2024! SHARK TANK Tuesday, March 5, 7:45AM - 9:26AM Room: Grand Ballroom C-E, Concourse Level POSTER ABSTRACT Tuesday, March 5, 8:00AM - 5:00PM Room: Ballroom Fover, Concourse Level "Non-Invasive Multisensor Algorithm to Predict Worsening Heart Failure by Change in Natriuretic Peptides" AKA #BloodlessBloodTests Authors: Dr. Andrew J. Sauer, MD (Saint Luke's Mid America Heart Institute) Dr. Dipti Itchhaporia, M.D., MACC, FAHA, FESC (Hoag Health System) Dr. Zubair?Shah (The University of Kansas Health System) Dr. AMARINDER BINDRA (Baylor Scott & White Health) Dr. Rohan Goswami (MAYO CLINIC FLORIDA) Dr. Anthony Magalski?(University of Louisville School of Medicine Jewish Hospital) Dr. David Miranda (Minneapolis Heart Institute Foundation) Javier Echenique, Sidhant Jena, Michael C. Brown Dr. Ioannis Mastoris, MD, FACC, Kartik Munshi, Eva Adams, Karen Haffey, Carmen Cook, Joost Felius, PhD, My Nguyen, Gene Graham, Haleh Armian, Junko Hara, Dr. Shriya Sharma, Dr. Caitlyn Luce, Dr. Aarti Desai, Ming Jay Chow, Amit Singh, Soumil Chugh, Mo Chen, Dinesh Mandepudi #heartfailure, #remotepatientmonitoring
-
-
?? Day 9 - General Prognostics Revolutionizing remote chronic disease management with AI-driven Bloodless Blood Tests Heart failure is a chronic and progressive condition that affects over 26 million individuals globally. These patients constitute 30% of global hospital readmissions, totaling $6.6B in costs in 2019, and tripling by 2025. Less than 1% of HF patients are on optimal guideline directed medical therapy (GDMT) due to poor remote monitoring options, causing patients that could otherwise be stabilized to end up readmitted. Could remote monitoring be the key to keeping cardiologists informed about their patients' therapy responses more effectively? Read more: https://lnkd.in/dW8nKdXe #EQTFoundationHolidayHope #25impactstartups
-
-
Co-Founder@General Prognostics (GPx) | Revolutionizing Chronic Disease Management
Javier Echenique and I are proud to announce the completion of enrollment in the #CardioID TRIBE-HF2 study, monitored over 230 patients. We extend our gratitude to our clinical partners who worked tirelessly with us to improve the outcome for heart failure patients. #heartfailure #clinicalresearch #BloodlessBloodTests #remotepatientmonitoring General Prognostics (GPx)
-